Larotrectinib Use in A Patient with A Diffuse High-Grade Glioma with NTRK2 Fusion
Publication
, Journal Article
Brown, C; Patel, MP; Calabrese, E; Cummings, TJ; Patel, AP; Ashley, DM
Published in: International Journal of Clinical Case Reports and Reviews
May 7, 2025
Duke Scholars
Published In
International Journal of Clinical Case Reports and Reviews
DOI
Publication Date
May 7, 2025
Volume
25
Issue
5
Citation
APA
Chicago
ICMJE
MLA
NLM
Brown, C., Patel, M. P., Calabrese, E., Cummings, T. J., Patel, A. P., & Ashley, D. M. (2025). Larotrectinib Use in A Patient with A Diffuse High-Grade Glioma with NTRK2 Fusion. International Journal of Clinical Case Reports and Reviews, 25(5). https://doi.org/10.31579/2690-4861/799
Brown, Casey, Mallika P. Patel, Evan Calabrese, Thomas J. Cummings, Anoop P. Patel, and David M. Ashley. “Larotrectinib Use in A Patient with A Diffuse High-Grade Glioma with NTRK2 Fusion.” International Journal of Clinical Case Reports and Reviews 25, no. 5 (May 7, 2025). https://doi.org/10.31579/2690-4861/799.
Brown C, Patel MP, Calabrese E, Cummings TJ, Patel AP, Ashley DM. Larotrectinib Use in A Patient with A Diffuse High-Grade Glioma with NTRK2 Fusion. International Journal of Clinical Case Reports and Reviews. 2025 May 7;25(5).
Brown, Casey, et al. “Larotrectinib Use in A Patient with A Diffuse High-Grade Glioma with NTRK2 Fusion.” International Journal of Clinical Case Reports and Reviews, vol. 25, no. 5, May 2025. Manual, doi:10.31579/2690-4861/799.
Brown C, Patel MP, Calabrese E, Cummings TJ, Patel AP, Ashley DM. Larotrectinib Use in A Patient with A Diffuse High-Grade Glioma with NTRK2 Fusion. International Journal of Clinical Case Reports and Reviews. 2025 May 7;25(5).
Published In
International Journal of Clinical Case Reports and Reviews
DOI
Publication Date
May 7, 2025
Volume
25
Issue
5